Summit Therapeutics

Summit Therapeutics Current Liabilities

The Current Liabilities of Summit Therapeutics (SMMT) as of Nov 22, 2026 is 41.73 M USD. In the previous year, Current Liabilities was 20.41 M USD — a change of 104.50% (higher).

Current Liabilities

41.73 MUSD

YoY

104.50%

Last updated:

Current Liabilities of Summit Therapeutics is 2024 41.73 M USD. Current Liabilities of Summit Therapeutics was 2023 20.41 M USD. It decreases by 104.50% higher compared to the previous year.

The Summit Therapeutics Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
17.56 M USD
Jan 1, 2019
13.80 M USD
Jan 1, 2020
19.90 M USD
Jan 1, 2021
25.60 M USD
Jan 1, 2022
38.90 M USD
Jan 1, 2023
20.41 M USD
Jan 1, 2024
41.73 M USD
Jan 1, 2025 (e)
72.99 M USD
The Summit Therapeutics Current Liabilities history
YEARCurrent LiabilitiesYoY
est72.99 MUSD+74.91%
41.73 MUSD+104.50%
20.41 MUSD-47.54%
38.90 MUSD+51.95%
25.60 MUSD+28.64%
19.90 MUSD+44.20%
13.80 MUSD-21.41%
17.56 MUSD-46.13%
32.60 MUSD+762.43%
3.78 MUSD+148.68%
1.52 MUSD+25.62%
1.21 MUSD+9.01%
1.11 MUSD-40.96%
1.88 MUSD-43.37%
3.32 MUSD+128.97%
1.45 MUSD+104.23%
710,000.00USD+273.68%
190,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Current Liabilities of Summit Therapeutics is 41.73 M USD in 2024.

Current Liabilities of Summit Therapeutics changed from 20.41 M USD to 41.73 M USD, representing a 104.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Summit Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Summit Therapeutics

All Key Metrics — Summit Therapeutics